Combination Therapy with Dipyridamole and Clopidogrel for Secondary Stroke Prevention in Aspirin-Intolerant Patients After Myocardial Infarction: Results of a Nationwide Case-Control Study
ConclusionNo differences were observed in the 12-year survival rate between clopidogrel and clopidogrel –dipyridamole groups. The two groups had balanced event-free survival in recurrent stroke, ICH, GI bleeding, and myocardial infarction.
Source: CNS Drugs - Category: Neurology Source Type: research
More News: Angioplasty | Aspirin | Bleeding | Clopidogrel | Coronary Angioplasty | Gastroenterology | Heart Attack | Hemorrhagic Stroke | Neurology | Percutaneous Coronary Intervention | Plavix | Stroke | Study